Advertisement
UK markets open in 2 hours 19 minutes
  • NIKKEI 225

    37,929.91
    +301.43 (+0.80%)
     
  • HANG SENG

    17,626.75
    +342.21 (+1.98%)
     
  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD FUTURES

    2,348.70
    +6.20 (+0.26%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,430.32
    -3.50 (-0.01%)
     
  • CMC Crypto 200

    1,387.75
    +5.18 (+0.37%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip

2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip

Dividend Kings are among the most steady corporations on the market. While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group. Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.